Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

Spremljeno u:
Bibliografski detalji
Izdano u:Hemasphere
Glavni autori: Momotow, Jesko, Goergen, Helen, Behringer, Karolin, Bröckelmann, Paul J., Borchmann, Sven, Tresckow, Bastian v., Kobe, Carsten, Engert, Andreas, Sasse, Stephanie
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2019
Teme:
Letter
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6919467/
https://ncbi.nlm.nih.gov/pubmed/31942546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000293
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items